Statin therapy and plasma cortisol concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials

Pharmacological Research

Volumn 103, Issue , 2016, Pages 17-25

  Sahebkar, Amirhossein ^a,b   Rathouska, Jana ^c   Simental Mendía, Luis E ^d   Nachtigal, Petr ^c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c CHARLES UNIVERSITY   (Czech Republic)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Cortisol level; Meta analysis; Randomized controlled trial; Statin

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; HYDROCORTISONE;

ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CHOLESTEROL SYNTHESIS; CYTOKINE PRODUCTION; DIASTOLIC BLOOD PRESSURE; HOMEOSTASIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROPHILICITY; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOMODULATION; ISOPRENYLATION; LIPOPHILICITY; META ANALYSIS (TOPIC); MOLECULAR DYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGRESSION ANALYSIS; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT RESPONSE; BLOOD; META ANALYSIS;

HUMANS; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84947808489     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.10.013     Document Type: Article

References (52)

1. F. Mach, W.F. Riesen, N. Rodondi, and A. Von Eckardstein Statin treatment in primary and secondary prevention - a statement Rev. Med. Suisse 10 2014 2430 2433
2. S. Paulo, S. Fernandes, R. Vizinho, and A.V. Carneiro Statin therapy in the primary and secondary prevention of coronary artery disease in patients with type 2 diabetes. A scientific review Rev. Port. Cardiol. 23 2004 1461 1482
3. J.K. Liao, and U. Laufs Pleiotropic effects of statins Annu. Rev. Pharmacol. Toxicol. 45 2005 89 118
4. T. Miida, S. Hirayama, and Y. Nakamura Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia J. Atheroscler. Thromb. 11 2004 253 264
5. I. Ford, H. Murray, C.J. Packard, J. Shepherd, P.W. Macfarlane, and S.M. Cobbe Long-term follow-up of the West of Scotland Coronary Prevention Study N. Engl. J. Med. 357 2007 1477 1486
6. P. Calabro, and E.T. Yeh The pleiotropic effects of statins Curr. Opin. Cardiol. 20 2005 541 546
7. G. Ferretti, T. Bacchetti, and A. Sahebkar Effect of statin therapy on paraoxonase-1 status: a systematic review and meta-analysis of 25 clinical trials Prog. Lipid Res. 28 2015 10.1016/j.plipres.2015.08.003 pii: S0163-7827(15)00041-7
8. Q. Zhou, and J.K. Liao Pleiotropic effects of statins: basic research and clinical perspectives Circ. J. 74 2010 818 826
9. U. Landmesser, F. Bahlmann, M. Mueller, S. Spiekermann, N. Kirchhoff, S. Schulz, C. Manes, D. Fischer, K. de Groot, D. Fliser, G. Fauler, W. Marz, and H. Drexler Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans Circulation 111 2005 2356 2363
10. T.J. Stalker, A.M. Lefer, and R. Scalia A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid Br. J. Pharmacol. 133 2001 406 412
11. L.M. Rasmussen, P.R. Hansen, M.T. Nabipour, P. Olesen, M.T. Kristiansen, and T. Ledet Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells Biochem. J. 360 2001 363 370
12. G. Weitz-Schmidt, K. Welzenbach, V. Brinkmann, T. Kamata, J. Kallen, C. Bruns, S. Cottens, Y. Takada, and U. Hommel Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site Nat. Med. 7 2001 687 692
13. P.M. Ridker, and J.S. Group Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial Circulation 108 2003 2292 2297
14. M. Banach, C. Serban, A. Sahebkar, D.P. Mikhailidis, S. Ursoniu, K.K. Ray, J. Rysz, P.P. Toth, P. Muntner, S. Mosteoru, H.M. Garcia-Garcia, G.K. Hovingh, J.J. Kastelein, and P.W. Serruys Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies BMC Med. 13 2015 229
15. A. Sahebkar, C. Serban, D.P. Mikhailidis, A. Undas, G.Y. Lip, P. Muntner, V. Bittner, K.K. Ray, G.F. Watts, G.K. Hovingh, J. Rysz, J.J. Kastelein, M. Banach, and Lipid and Blood Pressure Meta-analysis Collaboration Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials Thromb. Haemost. 114 2015 546 557
16. G. Pasterkamp, and G.W. van Lammeren Pleiotropic effects of statins in atherosclerotic disease Expert Rev. Cardiovasc.Ther. 8 2010 1235 1237
17. U. Ikeda, and K. Shimada Pleiotropic effects of statins on the vascular tissue Curr. Drug Targets Cardiovasc. Haematol. Disord. 1 2001 51 58
18. M. Geslin, and B. Auperin Relationship between changes in mRNAs of the genes encoding steroidogenic acute regulatory protein and P450 cholesterol side chain cleavage in head kidney and plasma levels of cortisol in response to different kinds of acute stress in the rainbow trout (Oncorhynchus mykiss) Gen. Comp. Endocrinol. 135 2004 70 80
19. A.H. Hamrahian, T.S. Oseni, and B.M. Arafah Measurements of serum free cortisol in critically ill patients N. Engl. J. Med. 350 2004 1629 1638
20. W.Y. Almawi, and O.K. Melemedjian Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor J. Leukoc. Biol. 71 2002 9 15
21. H. Prigent, V. Maxime, and D. Annane Clinical review: corticotherapy in sepsis Crit. Care 8 2004 122 129
22. H. Engelberg Low serum cholesterol and suicide Lancet 339 1992 727 729
23. P.H. Steegmans, A.W. Hoes, A.A. Bak, E. van der Does, and D.E. Grobbee Higher prevalence of depressive symptoms in middle-aged men with low serum cholesterol levels Psychosom. Med. 62 2000 205 211
24. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, and P. Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 2009 b2535
25. J. Higgins, and S. Green Cochrane Handbook for Systematic Reviews of Interventions 2009 The Cochrane Collboration London Version 5.0.2.
26. M. Borenstein, L. Hedges, and J. Higgins Comprehensive Meta-Analysis 2005 Biostat Englewood, NJ Version 2
27. S.P. Hozo, B. Djulbegovic, and I. Hozo Estimating the mean and variance from the median, range, and the size of a sample BMC Med. Res. Methodol. 5 2005 13
28. A. Sutton, K. Abrams, D. Jones, T. Sheldon, and F. Song Methods for Meta-Analysis in Medical Research 2000 John Wiley & Sons West Sussex
29. A. Sahebkar Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis Phytother. Res. 28 2014 633 642
30. A. Sahebkar Does PPARgamma2 gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis DNA Cell Biol. 32 2013 188 198
31. S. Duval, and R. Tweedie Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 56 2000 455 463
32. M.T. Hyyppa, E. Kronholm, A. Virtanen, A. Leino, and A. Jula Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial Psychoneuroendocrinology 28 2003 181 194
33. A.M. Nugent, D. Neely, I. Young, I. McDowell, M. O'Kane, N. Bell, C.F. Stanford, and D.P. Nicholls Stress responses after treatment of hypercholesterolaemia with simvastatin Br. J. Clin. Pharmacol. 36 1993 474 477
34. M. Bohm, W. Herrmann, S. Wassmann, U. Laufs, and G. Nickenig Does statin therapy influence steroid hormone synthesis? Z. Kardiol. 93 2004 43 48
35. E.A. Stein, D.R. Illingworth, P.O. Kwiterovich Jr., C.A. Liacouras, M.A. Siimes, M.S. Jacobson, T.G. Brewster, P. Hopkins, M. Davidson, K. Graham, F. Arensman, R.H. Knopp, C. DuJovne, C.L. Williams, J.L. Isaacsohn, C.A. Jacobsen, P.M. Laskarzewski, S. Ames, and G.J. Gormley Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial JAMA 281 1999 137 144
36. S.B. Clauss, K.W. Holmes, P. Hopkins, E. Stein, M. Cho, A. Tate, A.O. Johnson-Levonas, and P.O. Kwiterovich Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia Pediatrics 116 2005 682 688
37. B. Venkatesh, L. Imeson, P. Kruger, J. Cohen, M. Jones, R. Bellomo, Australian and, New Zealand Intensive Care Society Clinical Trials Group, and STATInS Trial Investigators Elevated plasma-free cortisol concentrations and ratios are associated with increased mortality even in the presence of statin therapy in patients with severe sepsis Crit. Care Med. 43 2015 630 635
38. T.A. Wani, A. Samad, M. Tandon, G.S. Saini, P.L. Sharma, and K.K. Pillai The effects of rosuvastatin on the serum cortisol, serum lipid, and serum mevalonic acid levels in the healthy Indian male population AAPS PharmSciTech 11 2010 425 432
39. P. Duriez Mechanisms of actions of statins and fibrates Therapie 58 2003 5 14
40. C. Arnaud, and F. Mach Pleiotropic effects of statins in atherosclerosis: role on endothelial function, inflammation and immunomodulation Arch. Mal. Coeur. Vaiss. 98 2005 661 666
41. N. Gallo-Payet, and M.C. Battista Steroidogenesis-adrenal cell signal transduction Compr. Physiol. 4 2014 889 964
42. A.K. Parsaik, B. Singh, M.H. Murad, K. Singh, S.S. Mascarenhas, M.D. Williams, M.I. Lapid, J.W. Richardson, C.P. West, and T.A. Rummans Statins use and risk of depression: a systematic review and meta-analysis J. Affect. Disord. 160 2014 62 67
43. S. Het, and O.T. Wolf Mood changes in response to psychosocial stress in healthy young women: effects of pretreatment with cortisol Behav. Neurosci. 121 2007 11 20
44. E. Mandosi, M. Fallarino, A. Gatti, A. Carnovale, M. Rossetti, E. Lococo, B. Buchetti, S. Filetti, L. Lenti, and S. Morano Atorvastatin downregulates monocyte CD36 expression, nuclear NFkappaB and TNFalpha levels in type 2 diabetes J. Atheroscler. Thromb. 17 2010 539 545
45. K.A. Eccles, H. Sowden, K.E. Porter, S.M. Parkin, S. Homer-Vanniasinkam, and A.M. Graham Simvastatin alters human endothelial cell adhesion molecule expression and inhibits leukocyte adhesion under flow Atherosclerosis 200 2008 69 79
46. A. Rezaie-Majd, G.W. Prager, R.A. Bucek, G.H. Schernthaner, T. Maca, H.G. Kress, P. Valent, B.R. Binder, E. Minar, and M. Baghestanian Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients Arterioscler. Thromb. Vasc. Biol. 23 2003 397 403
47. B. Jilma, C. Joukhadar, U. Derhaschnig, F. Rassoul, V. Richter, M. Wolzt, G.T. Dorner, V. Petternel, and O.F. Wagner Levels of adhesion molecules do not decrease after 3 months of statin therapy in moderate hypercholesterolaemia Clin. Sci. (Lond.) 104 2003 189 193
48. T. Matsuda, Y. Toyohira, S. Ueno, M. Tsutsui, and N. Yanagihara Simvastatin inhibits catecholamine secretion and synthesis induced by acetylcholine via blocking Na+ and Ca2+ influx in bovine adrenal medullary cells J. Pharmacol. Exp. Ther. 327 2008 130 136
49. J. Liu, P. Heikkila, Q.H. Meng, A.I. Kahri, M.J. Tikkanen, and R. Voutilainen Expression of low and high density lipoprotein receptor genes in human adrenals Eur. J. Endocrinol. 142 2000 677 682
50. M. Banach, W.S. Aronow, C. Serban, A. Sahabkar, J. Rysz, L. Voroneanu, and A. Covic Lipids, blood pressure and kidney update 2014 Pharmacol. Res. 95-96 2015 111 125
51. A. Sahebkar, G.T. Chew, and G.F. Watts Recent advances in pharmacotherapy for hypertriglyceridemia Prog. Lipid Res. 56 2014 47 66
52. A. Sahebkar, and G.F. Watts New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes Clin. Ther. 35 2013 1082 1098